GRCE Grace Therapeutics, Inc.

Fundamentals / CIK 0001444192 / USD

Grace Therapeutics, Inc. reported $57.70M in total assets and a net loss of $21.41M through March 31, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GRCE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2019 to 2026), reported in USD.

$103.0M$51.52M$0-$48.17MFY 2019 Net Income: -$39.37M2019FY 2020 Net Income: -$25.51M2020FY 2021 Revenue: $196KFY 2021 Net Income: -$19.68M2021FY 2022 Revenue: $100.0MFY 2022 Net Income: -$9.82M2022FY 2023 Net Income: -$42.43M2023FY 2024 Net Income: -$12.85M2024FY 2025 Net Income: -$9.57M2025FY 2026 Net Income: -$7.79M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue -- -- -- -- $100.0M $196K -- --
Cost of Revenue -- -- -- -- $0 $76K -- --
Gross Profit -- -- -- -- $100.0M $120K -- --
Research & Development $2.40M $9.51M $4.68M $9.97M $5.56M $4.17M $15.97M $29.37M
Selling, General & Admin -- -- $6.94M $8.28M $9.78M $6.66M $8.46M $5.03M
Operating Income -$11.08M -$16.68M -$12.85M -$52.16M -$15.59M -$16.42M -$24.44M -$34.41M
EBITDA -$11.07M -$16.67M -$12.84M -$52.03M -$15.59M -$15.49M -$22.12M -$32.07M
Interest Income $685K $711K $911K $246K $77K $107K $336K $358K
Income Before Tax -$9.49M -$12.77M -$14.69M -$51.97M -$10.47M -$19.68M -$25.51M -$39.37M
Income Tax Expense -$1.70M -$3.20M -$1.83M -$9.54M -$648K $0 $0 $0
Net Income -$7.79M -$9.57M -$12.85M -$42.43M -$9.82M -$19.68M -$25.51M -$39.37M
Basic EPS -$0.47 -$0.79 -$1.35 -$5.71 -$1.62 -$7.98 -$1.80 -$4.38
Diluted EPS -$0.47 -$0.79 -$1.35 -$5.71 -$1.62 -$7.98 -$1.80 -$4.38
Basic Shares Outstanding 16.5M 12.1M 9.5M 7.4M 6.1M 2.5M 14.1M 9.1M
Diluted Shares Outstanding 16.5M 12.1M 9.5M 7.4M 6.1M 2.5M 14.1M 9.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $885K $697K $420K $462K $568K $955K $1.63M $2.19M
Operating Income -$2.29M -$15.92M -$3.01M -$2.45M -$2.53M -$3.09M -$3.18M -$3.70M
EBITDA -$2.29M -$15.91M -$3.01M -$2.45M -$2.53M -$3.09M -$3.18M -$3.70M
Interest Income $154K $141K $138K $170K $172K $205K $167K $138K
Income Before Tax -$2.14M -$15.79M -$2.88M -$2.31M -$938K -$3.36M -$382K -$4.76M
Income Tax Expense -$8.0K $0 -$1.70M $0 $0 $0 -$1.02M -$605K
Net Income -$2.13M -$15.79M -$1.18M -$2.31M -$938K -$3.36M $636K -$4.16M
Basic EPS -$0.11 -$0.91 -- -$0.14 -$0.06 -$0.21 -- -$0.36
Diluted EPS -$0.11 -$0.91 -- -$0.14 -$0.06 -$0.21 -- -$0.36
Basic Shares Outstanding 20.1M 17.3M -- 16.9M 15.9M 15.9M -- 11.5M
Diluted Shares Outstanding 20.1M 17.3M -- 16.9M 15.9M 15.9M -- 11.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $16.98M $22.13M $23.00M $27.88M $30.34M $50.94M $14.24M $16.87M
Short-Term Investments -- -- $0 $15K $13.32M $9.79M -- $8.89M
Cash & Short-Term Investments $16.98M $22.13M $23.00M $27.89M $43.66M $60.70M $14.24M $25.76M
Accounts Receivable, Net -- -- $722K $802K $548K $530K $546K $1.19M
Other Current Assets -- -- -- -- -- -- $195K $49K
Total Current Assets $17.38M $22.71M $24.01M $29.29M $45.28M $62.37M $18.46M $27.97M
Property, Plant & Equipment, Net $8.0K $15K $24K $104K $20.89M -- $1.91M $2.11M
Goodwill $8.14M $8.14M $8.14M $8.14M $12.96M -- -- --
Intangible Assets $41.13M $41.13M $41.13M $41.13M $69.81M $0 $4.24M $6.39M
Long-Term Investments -- -- -- -- -- -- -- $20K
Other Non-Current Assets -- -- -- -- -- -- $473K $417K
Total Non-Current Assets $49.27M $49.28M $49.29M $49.83M $83.34M $86K $4.39M $8.93M
Total Assets $66.65M $71.99M $73.30M $79.12M $128.6M $62.46M $22.85M $36.90M
Accounts Payable $702K $601K $1.01M $1.24M $1.68M $115K $1.71M $3.05M
Total Current Liabilities $2.15M $1.93M $1.68M $3.41M $3.26M $1.58M $7.39M $13.67M
Total Non-Current Liabilities $612K $3.45M $9.87M $7.76M $17.09M $5.22M $2.46M $12.18M
Total Liabilities $2.76M $5.38M $11.56M $11.17M $20.35M $6.80M $9.86M $25.85M
Total Debt (incl. Leases) -- -- -- $485K $295K $86K $147K --
Common Stock $1.0K $1.0K $1.0K $258.3M $258.0M $197.2M $137.4M $110.9M
Retained Earnings -$228.5M -$220.7M -$211.1M -$198.3M -$155.8M -$146.0M -$126.3M -$100.8M
Accumulated Other Comp. Income -$6.04M -$6.04M -$6.04M -$6.04M -$6.04M -$6.33M -$7.89M -$7.13M
Total Stockholders' Equity $63.90M $66.61M $61.74M $67.95M $108.3M $55.66M $12.99M $11.04M
Total Equity $63.90M $66.61M $61.74M $67.95M $108.3M $55.66M $12.99M $11.04M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $21.31M $13.76M $16.98M $18.67M $16.86M $20.00M $22.13M $11.05M
Cash & Short-Term Investments $21.31M $13.76M $16.98M $18.67M $16.86M $20.00M $22.13M $11.05M
Total Current Assets $21.96M $14.33M $17.38M $19.21M $17.30M $20.52M $22.71M $11.94M
Property, Plant & Equipment, Net -- -- $8.0K -- -- -- $15K --
Goodwill $8.14M $8.14M $8.14M $8.14M $8.14M $8.14M $8.14M $8.14M
Intangible Assets $27.59M $27.59M $41.13M $41.13M $41.13M $41.13M $41.13M $41.13M
Total Non-Current Assets $35.74M $35.74M $49.27M $49.28M $49.28M $49.28M $49.28M $49.28M
Total Assets $57.70M $50.07M $66.65M $68.49M $66.58M $69.81M $71.99M $61.22M
Accounts Payable $410K $408K $702K $114K $459K $1.34M $601K $665K
Total Current Liabilities $1.61M $1.25M $2.15M $1.28M $1.25M $2.31M $1.93M $1.97M
Total Non-Current Liabilities $604K $612K $612K $2.31M $2.51M $3.94M $3.45M $7.11M
Total Liabilities $2.22M $1.86M $2.76M $3.60M $3.76M $6.25M $5.38M $9.09M
Common Stock $2.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$246.4M -$244.3M -$228.5M -$227.3M -$225.0M -$224.0M -$220.7M -$221.3M
Accumulated Other Comp. Income -$6.04M -$6.04M -$6.04M -$6.04M -$6.04M -$6.04M -$6.04M -$6.04M
Total Stockholders' Equity $55.48M $48.21M $63.90M $64.89M $62.82M $63.55M $66.61M $52.14M
Total Equity $55.48M $48.21M $63.90M $64.89M $62.82M $63.55M $66.61M $52.14M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -$7.79M -$9.57M -$12.85M -$42.43M -$9.82M -$19.68M -$25.51M -$39.37M
Depreciation & Amortization $7.0K $7.0K $11K $124K $0 $924K $2.32M $2.33M
Stock-Based Compensation $798K $730K $913K $1.81M $1.34M $1.17M $1.95M --
Change in Receivables $106K $596K $80K -$302K $18K -$58K $581K -$620K
Change in Payables $543K -$84K -$1.65M $411K -- -- -- --
Operating Cash Flow -$8.87M -$14.90M -$12.33M -$15.91M -$17.23M -$14.32M -$22.95M --
Investing Cash Flow $0 $0 $104K $13.15M -$3.52M -$9.86M $8.14M --
Common Stock Issued -- -- $0 $304K $0 $59.33M $6.98M --
Financing Cash Flow $3.71M $14.03M $7.36M $304K $0 $59.49M $13.18M --
Net Change in Cash -$5.16M -$872K -$4.87M -$2.46M -$20.60M $36.70M -$2.63M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.13M -$15.79M -$1.18M -$2.31M -$938K -$3.36M $636K -$4.16M
Depreciation & Amortization $1.0K $2.0K $2.0K $3.0K $0 $2.0K $2.0K $2.0K
Stock-Based Compensation $197K $105K $182K $108K $206K $302K $130K $160K
Change in Receivables $0 $0 $0 $0 $0 $106K $175K $114K
Change in Payables $229K -$897K $863K $36K -$1.07M $711K -$371K -$703K
Operating Cash Flow -$1.78M -$3.22M -$1.70M -$2.23M -$3.14M -$1.80M -$2.95M -$4.12M
Investing Cash Flow -- -- $0 $0 $0 $0 $0 $15K
Financing Cash Flow $9.34M $0 $0 $4.04M $0 -$327K $14.03M $0
Net Change in Cash $7.55M -$3.22M -$1.70M $1.81M -$3.14M -$2.13M $11.08M -$4.10M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Gross Margin -- -- -- -- 100.0% 61.2% -- --
Operating Margin -- -- -- -- -15.6% -8377.0% -- --
Net Profit Margin -- -- -- -- -9.8% -10039.8% -- --
Return on Equity (ROE) -12.2% -14.4% -20.8% -62.4% -9.1% -35.4% -196.3% -356.4%
Return on Assets (ROA) -11.7% -13.3% -17.5% -53.6% -7.6% -31.5% -111.6% -106.7%
Current Ratio 8.10x 11.77x 14.26x 8.59x 13.89x 39.50x 2.50x 2.05x
Quick Ratio 7.91x 11.47x 14.09x 8.41x 13.56x 38.78x 2.00x 1.97x
Debt to Equity -- -- -- 0.01x 0.00x 0.00x 0.01x --
Revenue Growth (YoY) -- -- -- -- +50920.4% -- -- --
Gross Profit Growth (YoY) -- -- -- -- +83233.3% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -38.6% -41.9% -12.2% -9.2% -12.4% -16.2% -14.4% -25.6%
Return on Assets (ROA) -37.1% -40.4% -11.7% -8.7% -11.7% -14.8% -13.3% -21.8%
Current Ratio 13.61x 11.47x 8.10x 14.96x 13.89x 8.87x 11.77x 6.06x
Quick Ratio 13.20x 11.00x 7.91x 14.54x 13.54x 8.64x 11.47x 5.61x
Net Income Growth (YoY) -- -- -285.2% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001444192) · from March 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:02 UTC · Open in terminal